Patents by Inventor An Cerdobbel

An Cerdobbel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin
    Patent number: 11897944
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: February 13, 2024
    Assignee: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
  • SERUM ALBUMIN BINDERS
    Publication number: 20230060574
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Application
    Filed: June 29, 2022
    Publication date: March 2, 2023
    Applicant: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
  • IMPROVED SERUM ALBUMIN BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
    Publication number: 20230050615
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Application
    Filed: June 29, 2022
    Publication date: February 16, 2023
    Applicant: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
  • Serum albumin binding immunoglobulin single variable domains
    Patent number: 11414480
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: August 16, 2022
    Assignee: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
  • Serum albumin binders
    Patent number: 11414481
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: August 16, 2022
    Assignee: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, An Cerdobbel
  • IMPROVED SERUM ALBUMIN BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
    Publication number: 20190367596
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Application
    Filed: December 7, 2017
    Publication date: December 5, 2019
    Applicant: Ablynx N.V.
    Inventors: Stephanie Staelens, Soren Steffensen, Erika Morizzo, Raf Ponsaerts, Ingrid Ottevaere, An Cerdobbel
  • SERUM ALBUMIN BINDERS
    Publication number: 20190367598
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Application
    Filed: January 17, 2018
    Publication date: December 5, 2019
    Applicant: Ablynx N.V.
    Inventors: Stephanie STAELENS, Soren STEFFENSEN, Erika MORIZZO, An CERDOBBEL
  • SERUM ALBUMIN BINDERS
    Publication number: 20190367597
    Abstract: The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.
    Type: Application
    Filed: January 17, 2018
    Publication date: December 5, 2019
    Applicant: Ablynx N.V.
    Inventors: Stephanie STAELENS, Soren STEFFENSEN, Erika MORIZZO, An CERDOBBEL
  • THERMOSTABLE SUCROSE PHOSPHORYLASE
    Publication number: 20130029384
    Abstract: The present invention relates to a sucrose phosphorylase from Bifidobacterium adolescentis which is useful as a biocatalyst in carbohydrate conversions at high temperatures. Indeed, the biocatalysts of the present invention are enzymatically active for a time period of at least 16 h and up to 1 to 2 week(s) at a temperature of at least 60° C. The biocatalysts of the present invention are: a) immobilized on an enzyme carrier, or b) are part of a cross-linked enzyme aggregate (CLEA), and/or c) are mutated, and/or d) are enzymatically active in the continuous presence of their substrate.
    Type: Application
    Filed: April 1, 2011
    Publication date: January 31, 2013
    Applicant: UNIVERSITEIT GENT
    Inventors: An Cerdobbel, Tom Desmet, Wim Soetaert